Nabeela Nathoo, MD, PhD, FRCPC

Happy to share @andreuvilaseca7 et al collaboration with @ESotirchos on the TRUE-MOGAD Score to discriminate true & false positive MOG-IgG ➡️ We have created an online calculator for ease of use: news.mayocliniclabs.com/true-mogad-cal… The article link is below: 👇 neurology.org/doi/10.1212/NX…

Rescue cyclophosphamide treatment was used in 23 people with #MultipleSclerosis from 2009 to 2024, and was associated with improvement in relapse-associated disability. 🔓MSJ-ETC study from @UBC ▶️ journals.sagepub.com/doi/full/10.11…

Here's a sneak peek of the April #MultipleSclerosis and Related Disorders issue, with guest editor Dr. Andrew Solomon, publishing next week! @AANmember @LyellJ #MedEd #NeuroX #NeuroTwitter

Sex-specificity in PD, while recognized, remains underestimated in research and clinical management. Here are just some of the ways women may experience PD differently. #IWD2026 loom.ly/R5a8yqs

They take care of the sickest patients. They’re at the bedside on weekends. On holidays. In the middle of the night. They are the altruistic, diligent, compassionate, and creative engine of our academic healthcare mission. Whether we know it or not, we have all benefited from their care. Today is Thank a Resident Day. If you see a resident or fellow today, please thank them. (It’s OK to thank them the rest of the year too.) If there’s a trainee or group you want to call out in particular, drop it in the replies!

🚨 ACTRIMS 2026 | MS Research A novel PET imaging study is tracking how cladribine tablets may reduce microglial activation in patients with MS experiencing progression without relapse activity. Read more 👇 hubs.li/Q042cxLL0 #ACTRIMSForum #MultipleSclerosis #MSResearch #ClinicalTrials

This analysis of the French MS registry suggests the superiority of highly effective disease modifying therapies in preventing disability progression is primarily due to suppression of relapses and new MRI lesions rather than "PIRA" pubmed.ncbi.nlm.nih.gov/41689266/

February is #BlackHistoryMonth 💛❤️💚🖤 #NMOSD disproportionately affects Black Americans: ~13/100k prevalence vs ~5/100k in White Americans, ~28% of U.S. NMOSD patients are Black, with higher incidence and worse pain & cognitive outcomes. Share your experiences.

This multicenter case series highlights 5 cases of enterovirus encephalitis among people with MS receiving ocrelizumab, presenting with fever, encephalopathy, and gait changes (and myocarditis in 1 case): hubs.la/Q03-t51H0 @samanthabanksMD @EoinFlanagan14 @neuronathoo

Happy to share our @PracticalNeurol review article on diagnosing #PML, which includes a proposed diagnostic algorithm that builds on the 2013 @AANmember PML diagnostic criteria. Great work by @KatherineSawic1 and colleagues @LHSCCanada @WesternU @UofT pn.bmj.com/content/early/…

Our lab, located at the University of Alberta (Canada), is hiring a postdoctoral scholar and/or PhD student to work on the contribution of genetic mutations to neurological disorder mechanisms and response to treatments. Please share widely! can-acn.org/postdoctoral-f…

Functional Neurologic Symptoms in Multiple Sclerosis: Estimated Prevalence and Associated Comorbidities hubs.la/Q03YMrJG0

@EoinFlanagan14 @UAlberta_FoMD @MayoClinicNeuro

Excited to share @SamanthaBanksMD et al study of 5 pwMS with enterovirus encephalitis on ocrelizumab from 3 centres: ➡️seen in young pwMS, sometimes with HFMD prior ➡️low IgG in all ➡️MRI abN: thalamus, substantia nigra, cerebellum ➡️high morbidity neurology.org/doi/10.1212/NX…

This case report describes a unique presentation of Kelch-like protein 11 antibody-associated paraneoplastic encephalitis in an 81-year-old woman with a high-grade neuroendocrine carcinoma consistent with metastatic Merkel cell carcinoma. ja.ma/485ifgW

📢 November issue is now available ▶️ journals.sagepub.com/toc/MSJ/current ...and the cover goes to @SamanthaBanksMD @MayoClinicNeuro @MayoClinic with their study on deep brain stimulation as a potential treatment for severe tremor in #MultipleSclerosis ▶️ journals.sagepub.com/doi/abs/10.117…

Gait monitoring with wearable and depth video are both viable options for objective quantification of gait in people with MS in a clinical setting @MayoClinicNeuro sciencedirect.com/science/articl…

Can changes in sleep or dreams be early warning signs of Parkinson’s disease? Does tracking our sleep with smartwatches work? Come to our free Community Health Fair on Nov 15 for expert talks, health resources and giveaways. ualberta.ca/en/department-…

Deep brain stimulation is a potential treatment for severe tremor in #MultipleSclerosis, by not provoking relapses, optimizing tremor control and maintaining MRI access. Study from @SamanthaBanksMD @MayoClinicNeuro @MayoClinic ▶️ journals.sagepub.com/doi/abs/10.117…

⭐️ DBS did not lead to worsened EDSS ⭐️Those with baseline mild (EDSS 3 or less) or severe (EDSS 6.5 or more) more consistently had sustained improvement, potentially due to ability to tolerate stimulation side effects